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1.1. Document Development Process
1.1.1. Writing Committee Organization
The writing committee was selected to represent the
American College of Cardiology (ACC), Society for
Vascular Medicine (SVM), American Board of Internal
Medicine (ABIM), and American Board of Vascular
Medicine (ABVM), and included a cardiovascular
training program director, a vascular medicine pro-
gram training director, early-career vascular medicine
experts, and highly experienced specialists repre-
senting both the academic and community-based
practice settings. The committee also included phy-
sicians experienced in deﬁning and applying training
standards according to the 6 general competency do-
mains promulgated by the Accreditation Council for
Graduate Medical Education (ACGME) and American
Board of Medical Specialties (ABMS) and endorsed by
the ABIM. The ACC determined that relationships
with industry or other entities were not relevant to
the creation of this general cardiovascular training
statement. Employment and afﬁliation details for
authors and peer reviewers are provided in
Appendixes 1 and 2, respectively, along with disclo-
sure reporting categories. Comprehensive disclosure
information for all authors, including relationships,
rwith industry and other entities, is available as an
online supplement to this document.
1.1.2. Document Development and Approval
The writing committee developed the document,
approved it for review by individuals selected by the
ACC and SVM, and then addressed the peer reviewers’
comments. The document was revised and posted for
public comment from December 20, 2014, to January 6,
2015. Authors addressed the additional comments
from the public to complete the document. The ﬁnal
document was approved by the Task Force, COCATS
Steering Committee, and ACC Competency Manage-
ment Committee; ratiﬁed by the ACC Board of Trustees
in March, 2015; and endorsed by the SVM. This docu-
ment is considered current until the ACC Competency
Management Committee revises or withdraws it.
1.2. Background and Scope
Cardiovascular physicians frequently encounter pa-
tients with peripheral vascular diseases. Athero-
thrombosis, in particular, is a systemic disorder with
clinical manifestations in the peripheral circulation.
These and other vascular diseases account for sub-
stantial cardiovascular morbidity and mortality.
Moreover, technological advances in imaging tech-
niques and endovascular therapies have brought the
management of vascular diseases ﬁrmly into the
sphere of the cardiovascular medicine specialist. As
part of a broader effort to standardize training criteria
for all aspects of cardiovascular medicine, this Task
Force was charged with updating previously-
published adult vascular medicine training guide-
lines (1,2) on the basis of changes in the ﬁeld since
2008. One modiﬁcation presented by this update is the
transfer of the training recommendations on catheter-
based peripheral vascular interventions to the COCATS
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tions with other cardiovascular interventional training
components. The Task Force also updated previously
published standards to address the evolving framework of
competency-based medical education described by the
ACGME Outcomes Project and by the 6 general compe-
tencies endorsed by the ACGME and ABMS. The back-
ground and overarching principles governing fellowship
training are provided in the COCATS 4 Introduction, and
readers should become familiar with this foundation
before considering the details of training in a subdiscipline
like vascular medicine. The Steering Committee and Task
Force recognize that implementation of these changes in
training requirements will occur incrementally.
For most areas of cardiovascular medicine, 3 levels of
training are delineated:
n Level I training, the basic training required to become a
competent cardiovascular consultant, is required of all
cardiovascular fellows and can be accomplished as part
of a standard 3-year training program in cardiovascular
medicine. All cardiovascular fellows should receive
basic training in vascular medicine and acquire sufﬁ-
cient knowledge to care for most patients with vascular
disease.
n Level II training refers to the additional training in 1 or
more areas that enables some cardiovascular specialists
to perform or interpret speciﬁc diagnostic tests and
procedures or render more specialized care for patients
and conditions. This level of training is recognized for
those areas in which an accepted instrument or
benchmark, such as a qualifying examination, is avail-
able to measure speciﬁc knowledge, skills, or compe-
tence. Level II training in selected areas may be
achieved by some trainees during the standard 3-year
cardiovascular fellowship, depending on their career
goals and use of elective rotations. It is anticipated that
during a standard 3-year cardiovascular fellowship
training program, sufﬁcient time will be available for
the trainee to receive Level II training in a speciﬁc
subspecialty. In the case of vascular medicine, Level II
training can be elected by fellows seeking additional
expertise in interpreting noninvasive diagnostic tests
and evaluating and managing patients with peripheral
vascular diseases. Level II training is also recom-
mended prior to or in conjunction with training in
catheter-based peripheral vascular intervention (see
COCATS 4 Task Force 10 report).
n Level III training requires additional training and
experience beyond the cardiovascular fellowship to
acquire specialized knowledge and competencies in
performing, interpreting, and training others to perform
speciﬁc procedures or render advanced specialized
care at a high level of skill. In the case of vascularmedicine, Level III training pertains to advanced
knowledge in diagnostic and therapeutic modalities for
evaluating and managing vascular disease and leads to
the ability to direct a vascular laboratory, train others,
and conduct advanced research in vascular medicine.
Level III training is described here only in broad terms
to provide context for trainees and clarify that these
advanced competencies are not covered during the
cardiovascular fellowship. The additional exposure and
requirements for Level III training will be addressed in a
subsequent, separately published Advanced Training
Statement.
The knowledge and competencies recommended at
each level of training are based on published guidelines,
competency statements, and the experience and opinions
of the writing group. It is assumed that training is directed
by appropriately trained mentors and that satisfactory
completion of training is documented by the program
director. The milestones required for each level of
training are summarized in Section 4.
2. GENERAL STANDARDS
The ACC and the SVM have addressed training re-
quirements and guidelines for vascular medicine training
(1,2). The recommendations are congruent and address
faculty, facility requirements, emerging technologies, and
clinical practice. We strongly recommend that candidates
for the ABIM examination for certiﬁcation in cardiovas-
cular diseases, as well as those seeking certiﬁcation from
the ABVM, review the speciﬁc examination requirements
(3). Cardiovascular fellowship programs should satisfy the
requirements regarding faculty and facilities for training
in vascular medicine (1,2). The intensity of training and
required resources vary according to the level of training
provided.
2.1. Faculty and Facilities
2.1.1. Faculty
Trainees should be exposed to individuals with special
training in vascular medicine. In some institutions, lead-
ership of the vascular medicine component of training
will come from vascular medicine specialists. In other
programs, training in vascular medicine will be guided by
faculty in other disciplines such as general cardiology,
hematology, neurology, vascular surgery, and vascular or
interventional radiology. All faculty members responsible
for training fellows in vascular medicine should be board
certiﬁed or board eligible in their subspecialties.
Ideally, faculty will include individuals certiﬁed in
vascular medicine by the ABVM. Recognizing that this
may not be possible at all institutions, cardiovascular
fellows may spend time in other departments or divisions
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vascular studies and to evaluate and manage patients
with vascular disease. Faculty with expertise in disci-
plines relevant to vascular medicine, such as vascular
surgery, vascular radiology, hematology, neurology,
dermatology, and rheumatology, play important roles in
training cardiovascular fellows. Faculty should provide
didactic and practical education to fellows and deliver
appropriate feedback about the performance of trainees.
2.2. Facilities
The training institution should provide comprehensive
facilities for the care of patients with vascular disease and
include ofﬁces for outpatient evaluation and treatment,
inpatient vascular consultative services, a noninvasive
vascular laboratory accredited by the Intersocietal
Accreditation Commission (Intersocietal Accreditation
Commission Vascular Testing Division, formerly
Intersocietal Commission for the Accreditation of Vascular
Laboratories) (4), facilities for computed tomographic
angiography and magnetic resonance angiography, a pe-
ripheral vascular catheterization laboratory, and compre-
hensive vascular surgery and wound care programs.
2.3. Equipment
Noninvasive vascular laboratories require dedicated
equipment to performdiagnostic studies, including duplex
ultrasound units capable of high-resolution B-mode
(grayscale) imaging as well as color and spectral Doppler
analysis, equipment for physiological testing with appro-
priately sized cuffs to measure blood pressure at multiple
sites in the limbs, Doppler and plethysmographic devices
(e.g., pulse volume recordings, photoplethysmographic
sensors), and equipment for digital image recording and
archiving. Equipment required for cardiovascular
computed tomography, cardiovascular magnetic reso-
nance, and catheter-based angiography is discussed in the
COCATS 4 Task Force 7, 8, and 10 reports, respectively.
2.4. Ancillary Support
Ancillary support should be available to facilitate
appointment scheduling and follow-up; manage clinical
and ﬁnancial records; retrieve laboratory and other clin-
ical reports; enable telephone communications between
patients and providers (e-mailing optional); provide
clean, prepared examination and consultation rooms; and
properly contain, control, and remove medical waste.
3. TRAINING COMPONENTS
3.1. Didactic Program
3.1.1. Lectures and Conferences
Conferences for Level I training in vascular medicine for
cardiovascular fellows should include case presentationsand formal lectures that review diagnostic and therapeutic
approaches to vascular diseases. Case presentations
should illustrate the use of clinical tools, including
noninvasive laboratory testing, magnetic resonance,
computed tomographic and catheter-based angiography,
and therapeutic approaches for patients with vascular
diseases. Lectures should provide information regarding
vascular anatomy, pathobiology, and pathophysiology;
epidemiology and the natural history of peripheral
vascular disorders; diagnostic evaluation; perioperative
evaluation and management; and therapeutic options,
including the risks and beneﬁts of medical, endovascular,
and surgical approaches to vascular disease to comple-
ment teaching in the clinic and at the bedside.
In addition to the lectures and case presentations
described in the previous text for Level I trainees, didactic
activities for Level II and III trainees should include a
comprehensive longitudinal conference series on vascular
topics, including peripheral artery disease; renal artery
stenosis; mesenteric vascular disease and extracranial
cerebrovascular disease; aneurysmal disease of the aorta
and peripheral arteries; vasculitis; vasospastic and
temperature-related diseases; venous thromboembolism;
chronic venous insufﬁciency and varicose veins; lym-
phedema; less-common disorders such as ﬁbromuscular
dysplasia and arteriopathies associated with inherited
diseases of connective tissue; congenital vascular mal-
formations and arterial entrapment syndromes; leg ul-
cers; and the preoperative evaluation and perioperative
management of patients undergoing vascular surgery.
Conferences should also cover the noninvasive vascular
laboratory, including principles of vascular physiology,
vascular ultrasound imaging and Doppler ﬂow velocity
measurements, ultrasound physics, blood pressure mea-
surement and pulse volume recordings, transducer tech-
nology, imaging artifacts, and reviews of the noninvasive
evaluation of speciﬁc vascular diseases. Lectures and
case presentations should cover other vascular imaging
modalities such as magnetic resonance, computed tomo-
graphic, and catheter-based angiography. The lecture se-
ries should include regularly scheduled patient safety or
quality improvement conferences, journal clubs, or other
fora for interactive discussion of the established literature
and emerging scientiﬁc advances. Interaction with
vascular specialists from other disciplines at these con-
ferences is recommended.
3.2. Clinical Experience
Level I trainees should gain experience in vascular disease
management in both the inpatient and outpatient settings,
assisting in patient care in a manner that provides patient-
centered education. It is important that Level I trainees
evaluate and manage patients with arterial, venous, and
lymphatic disorders. Training in vascular medicine may
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diovascular clinical training period. During the course of
patient-based rotations, Level I trainees should encounter
and receive instruction in the bedside evaluation of pa-
tients with peripheral (limb) artery disease, renal and
mesenteric artery disease, extracranial carotid artery dis-
ease, thoracic and abdominal aortic aneurysms, acute
aortic syndromes, deep vein thrombosis, pulmonary em-
bolism, and chronic venous insufﬁciency. Program activity
should include appropriate use of vascular diagnostic
modalities (physiological testing; duplex ultrasound im-
aging; and magnetic resonance, computed tomographic,
and catheter-based angiography); indications for and use
of pharmacotherapy to prevent and treat atherosclerosis,
venous thromboembolism, and their risk factors; the role
of endovascular and surgical revascularization; assess-
ment of cardiovascular risk; and periprocedural/perioper-
ative management of patients undergoing endovascular
procedures and vascular surgery.
Level II training for a cardiovascular specialist
concentrating in vascular medicine should include the
evaluation and management of patients with vascular
disease in both the outpatient clinic and the hospital,
extending the skills acquired during Level I training.
Level II training must include performance and interpre-
tation of noninvasive vascular tests. Trainees should un-
derstand physiological and ultrasound vascular testing
and should perform and interpret segmental pressure
measurements, pulse volume recordings, and duplex ul-
trasonography for venous thrombosis, venous insufﬁ-
ciency, peripheral artery disease, abdominal aortic
aneurysm, renal and mesenteric artery disease, and ca-
rotid artery disease.
Level III training in vascular medicine should provide
the knowledge and skills to function as a vascular
specialist, including the ability to interpret patients’
clinical presentation, plan diagnostic testing, apply clin-
ical and laboratory information, and develop appropriate
management plans for patients across the entire range of
vascular diseases, including but not limited to peripheral
artery disease, renal artery disease, mesenteric vascular
disease, extracranial cerebrovascular disease, aneurysmal
disease of the aorta and peripheral arteries, vasculitis,
venous thromboembolism, chronic venous insufﬁciency,
varicose veins, lymphedema, leg ulcers, and Raynaud’s
phenomenon and other vasospastic and temperature-
related disorders. Trainees should also acquire skills to
evaluate patients before and after interventional periph-
eral vascular procedures.
3.3. Hands-On Experience
Trainees should perform physical examinations and
noninvasive vascular testing appropriate to their level of
training. Level I trainees should be able perform acomplete vascular examination and measure the ankle-
brachial index using a hand-held Doppler device and
should become familiar with the interpretation of
vascular laboratory reports as they apply to the nonin-
vasive assessment of obstructive arterial and venous
thromboembolic diseases affecting the vessels of the
lower extremities.
Level II and III trainees should independently perform
and interpret arterial physiological studies of the limbs
and vascular ultrasound examinations of the veins and
arteries of the limbs, abdominal vessels, and extracranial
carotid arteries. Additional experience in the vascular
laboratory during Level III training may include trans-
cranial Doppler examinations, treatment of femoral artery
pseudoaneurysms with ultrasound-guided compression
or thrombin injection, and ultrasound-guided treatment
of varicose veins. Level III training may include training
in wound care techniques, including debridement and
application of appropriate dressings.
4. SUMMARY OF TRAINING REQUIREMENTS
4.1. Development and Evaluation of Core Competencies
Training and requirements in vascular medicine address
the 6 general competencies promulgated by the ACGME/
ABMS and endorsed by the ABIM. These competency do-
mains are:medical knowledge, patient care and procedural
skills, practice-based learning and improvement, systems-
based practice, interpersonal and communication skills,
and professionalism. The ACC has used this structure to
deﬁne and depict the components of the core clinical
competencies for cardiovascular medicine. The curricular
milestones for each competency and domain also provide a
developmental roadmap for fellows as they progress
through various levels of training and serve as an under-
pinning for the ACGME/ABIM reporting milestones. The
ACC has adopted this format for its competency and
training statements, career milestones, lifelong learning,
and educational programs. Additionally, it has developed
tools to assist physicians in assessing, enhancing, and
documenting these competencies.
Table 1 delineates each of the 6 competency domains as
well as their associated curricular milestones for training
in vascular medicine. The milestones are categorized into
Level I, II, and III training (as previously deﬁned in this
document) and indicate the stage of fellowship training
(12, 24, or 36 months, and additional time points) by
which the typical cardiovascular trainee should achieve
the designated level. Given that programs may vary with
respect to the sequence of clinical experiences provided
to trainees, the milestones at which various competencies
are reached may also vary. Level I competencies may be
achieved at earlier or later time points. Acquisition of
Level II skills requires additional training that may be
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fellowship. Level III skills require additional training in a
dedicated advanced vascular medicine program after
completion of the general cardiovascular fellowship. The
table also describes examples of evaluation tools suitable
for assessing competence in each domain.
4.2. Duration and Structure of Training
Level I competencies must be obtained by all fellows
during the 3-year cardiovascular disease fellowship
training program. Level II competencies may be obtained
by selected fellows during the cardiovascular disease
fellowship depending on their career focus and elective
experiences. Level III competencies are noted as addi-
tional requirements for advanced training beyond the
standard 3-year fellowship. The duration and structure
of training required for the typical fellow to gain com-
petencies in Levels I, II, and III training in vascular
medicine are summarized in the following text. In
all cases, achievement of the competencies must be
assessed.
4.2.1. Level I Training Requirements
Level I training typically requires 2 months of exposure to
vascular medicine services, either as dedicated rotations
or in aggregate, to provide the knowledge, skills, and
attitudes required for diagnosis and management of
patients with vascular diseases (Table 1). Training should
focus on the value of the clinical history and examination
for diagnosis, and exposure to bedside testing, vascular
physiologic testing, duplex ultrasound imaging, and
other noninvasive angiographic imaging modalities
(computed tomographic and magnetic resonance angiog-
raphy). The curriculum should include testing methods,
indications, diagnostic criteria, and technical limitations.
Level I trainees should understand the advantages and
disadvantages of the various vascular testing modalities
for speciﬁc clinical conditions. Sufﬁcient exposure to
catheter-based angiography and endovascular procedures
should be provided to allow understanding of the roles of
these modalities in diagnosis and management. The Level
I trainee should understand basic concepts of surgical and
endovascular treatments, including indications, contra-
indications, and potential complications. Level I trainees
should also be instructed in the comprehensive evalua-
tion of patients undergoing vascular surgery, including
indications and risks of preoperative testing and man-
agement of perioperative cardiovascular problems and
complications. They should learn to recognize and
manage disorders associated with vascular diseases,
including hypertension, hypercholesterolemia, and dia-
betes mellitus, throughout the cardiovascular fellowship
and should know when it is appropriate to refer patientsto a vascular specialist for further evaluation and
intervention.
4.2.2. Level II Training Requirements
Level I training in vascular medicine is a prerequisite for
Level II training. In addition to the 24 months of clinical
training required for board eligibility in cardiovascular
medicine, further training, typically during the third
year, should enable the fellow to become more know-
ledgeable and skilled in vascular medicine and non-
invasive vascular laboratory procedures (1,2). At
completion of Level II training, the trainee should be
able to perform and interpret noninvasive vascular
diagnostic examinations. In addition to interpretation,
hands-on experience and familiarity with scanning pro-
tocols are required. Completion of the vascular labora-
tory curriculum during Level II or III training should
make the trainee eligible for the Physicians’ Vas-
cular Interpretation Examination (5) and meet the re-
quirements to serve as medical staff or medical director
of an accredited vascular laboratory. Trainees seeking
additional competency in vascular medicine during car-
diovascular fellowship should participate in additional
inpatient and outpatient vascular medicine consulta-
tions and noninvasive vascular laboratory activities, and
should observe magnetic resonance, tomographic, and
catheter-based angiography and interventions.4.2.3. Level II and III Noninvasive Vascular Laboratory Training
Expertise in the noninvasive vascular laboratory is
important for vascular medicine specialists and required
for Level II and III trainees. The curriculum should
include diagnostic testing procedures and equipment,
indications, diagnostic criteria, and technical limitations.
In addition to the curricular components, Level II and
III trainees should have extensive mentored experience
in interpreting vascular studies. The Physicians’ Vascular
Interpretation Examination should be successfully com-
pleted after either Level II or III training. Interpreta-
tion under faculty supervision of at least 500 studies
distributed across the vascular testing areas is a prereq-
uisite for the Physicians’ Vascular Interpretation Exami-
nation (5). These areas include duplex ultrasonography
of limb veins, limb arteries (including bypass grafts and
stents), carotid arteries, renal and mesenteric arteries,
and the abdominal aorta; physiological testing for pe-
ripheral artery disease; and transcranial Doppler exami-
nation. The vascular laboratory curriculum for the Level
III trainee should include laboratory quality and
accreditation processes, a review of correlation studies,
and participation in quality improvement activities, such
as peer review and cross-modality correlation studies.
TABLE 1 Core Competency Components and Curricular Milestones for Training in Vascular Medicine
Competency Component Milestones (Months)
MEDICAL KNOWLEDGE 12 24 36 Add
1 Know the anatomy of the peripheral arterial and venous systems. I
2 Know the causes and clinical epidemiology of atherosclerotic peripheral vascular disease, including the incidence
and prevalence, sex and ethnic differences, role of genetics, and the inﬂuence of traditional risk factors and
demographics on outcomes.
I
3 Know the pathophysiology of peripheral artery disease, including atherosclerosis, thrombosis, embolism,
entrapment, vasculitis, and vasospasm.
I
4 Know the pathophysiology, causes, and clinical epidemiology of aortic aneurysms. I
5 Know the pathophysiology, causes, and clinical epidemiology of acute aortic syndromes such as dissection and
intramural hematoma.
I
6 Know the pathophysiology, causes, and clinical epidemiology of deep vein thrombosis and pulmonary embolism. I
7 Know the pathophysiology, causes, and clinical epidemiology of cerebrovascular disease. I
8 Know the pathophysiology, causes, and clinical epidemiology of chronic venous insufﬁciency and varicose veins. I
9 Know the pathophysiology, causes, and clinical epidemiology of lymphedema. II
10 Know the cardinal symptoms and physical ﬁndings of peripheral atherosclerotic vascular diseases, including
peripheral artery disease, renal and mesenteric artery disease, extracranial cerebrovascular disease, and
abdominal aortic aneurysm.
I
11 Know the cardinal symptoms and physical ﬁndings of venous diseases including venous thromboembolism,
chronic venous insufﬁciency, and varicose veins.
I
12 Know the differentiating characteristics between arterial, venous, and neurotrophic lower extremity ulcers. II
13 Know the natural history and prognosis of deep vein thrombosis and pulmonary embolism. I
14 Know the natural history and prognosis of peripheral atherosclerotic vascular diseases including peripheral
artery disease, renal and mesenteric artery disease, extracranial carotid artery disease, and abdominal
aortic aneurysm.
I
15 Know the indications for noninvasive screening for abdominal aortic aneurysm. I
16 Know the indications for duplex ultrasound of the peripheral veins and carotid arteries and for duplex and
physiological testing of the peripheral arteries.
I
17 Know the indications for duplex ultrasonography of the renal and mesenteric arteries, arterial bypass grafts
and stents, aortic endografts, and intracranial vessels (i.e., transcranial Doppler).
II
18 Know the indications and contraindications for computed tomographic angiography and magnetic resonance
angiography in patients with suspected vascular disease.
I
19 Know the appropriate indications and laboratory tests to assess for inherited and acquired thrombophilia. I
20 Know the appropriate indications and laboratory tests to assess for vasculitis. I
21 Know the indications, contraindications, risks, clinical pharmacology, and interactions of drugs used to treat
atherosclerotic vascular diseases.
I
22 Know the indications, contraindications, risks, clinical pharmacology, and interactions of drugs used to treat
thrombotic disorders.
I
23 Know the indications, contraindications, risks, and expected outcomes for thrombolytic therapy for venous
thromboembolism (pulmonary embolism and deep vein thrombosis).
I
24 Know the indications and risks for surgical and endovascular treatments for acute aortic syndromes and the
expected outcomes.
I
25 Know the indications and risks for surgical and endovascular treatments for aortic aneurysm and the expected
outcomes.
I
26 Know the indications and risks for surgical and endovascular treatments for peripheral atherosclerotic
vascular diseases, including peripheral artery disease, renal and mesenteric artery disease, and extracranial
cerebrovascular disease, and the expected outcomes.
I
EVALUATION TOOLS: chart-stimulated recall, global evaluation, and in-training examination.
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TABLE 1 Core Competency Components, continued
Competency Component Milestones (Months)
PATIENT CARE AND PROCEDURAL SKILLS 12 24 36 Add
1 Skill to perform the comprehensive physical examination of the peripheral arteries, including palpation of the
abdominal aorta and peripheral pulses and auscultation for bruits.
I
2 Skill to perform physical examination for suspected peripheral venous disorders, including deep vein
thrombosis, varicose veins, and chronic venous insufﬁciency.
I
3 Skill to perform and interpret an ankle-brachial index measurement. I
4 Skill to perform physical examination maneuvers for arterial compression syndromes (e.g., thoracic outlet,
median arcuate ligament, and popliteal artery entrapment syndromes).
III
5 Skill to interpret limb segmental blood pressure measurements, pulse volume recordings and Doppler
waveforms, and treadmill vascular exercise tests.
II
6 Skill to interpret duplex ultrasound examinations of the extracranial carotid arteries, peripheral arteries,
abdominal aorta, renal and mesenteric arteries, and peripheral veins.
II
7 Skill to evaluate and manage aortic aneurysms including identiﬁcation of patients for whom surgical or
endovascular repair is indicated.
I
8 Skill to evaluate and manage acute aortic syndromes including identiﬁcation of patients for whom surgical or
endovascular therapy is indicated.
I
9 Skill to evaluate and manage patients with deep venous thrombosis and pulmonary embolism, including
identiﬁcation of patients for whom thrombolytic therapy is indicated.
I
10 Skill to perform preoperative risk assessment and manage patients undergoing vascular surgery. I
11 Skill to evaluate and manage lower extremity peripheral artery disease. I
12 Skill to evaluate and manage extracranial carotid artery disease. I
13 Skill to evaluate and manage patients with chronic venous insufﬁciency and varicose veins, including use of
compression therapy and identiﬁcation of patients for whom additional venous procedures are indicated
(i.e., sclerotherapy, ablation, or surgery).
III
14 Skill to evaluate lymphedema. II
15 Skill to manage lymphedema. III
16 Skill to diagnose and manage arterial access complications, including arteriovenous ﬁstula and arterial
pseudoaneurysms.
III
17 Skill to evaluate and manage lower extremity wounds, including indications for adjunctive imaging and biopsy,
indications and techniques for debridement, and selection of appropriate dressings.
III
18 Skill to evaluate and manage Raynaud’s phenomenon. III
19 Skill to evaluate and manage other temperature related disorders, including acrocyanosis, pernio, and
erythromelalgia.
III
20 Skill to evaluate and manage uncommon vascular disorders, including vascular compression syndromes
(e.g., thoracic outlet, popliteal entrapment), ﬁbromuscular dysplasia, arteriopathies associated with inherited
disorders of connective tissue, and congenital vascular malformations.
III
21 Skill to evaluate and manage peripheral and visceral artery aneurysms including identiﬁcation of patients for
whom surgical or endovascular repair is indicated.
III
EVALUATION TOOLS: chart-stimulated recall, direct observation, and global evaluation.
SYSTEMS-BASED PRACTICE 12 24 36 Add
1 Practice in a manner that balances appropriate utilization of ﬁnite resources with the net clinical beneﬁt for
the individual patient.
I
2 Utilize an interdisciplinary, coordinated approach for patient management. II
3 Utilize a coordinated approach for patient management, including coordination with rehabilitation services,
physical and occupational therapy, and consideration of employment-related issues.
III
4 Know the components of quality assurance in the noninvasive vascular laboratory, including certiﬁcation of
technical and medical personnel, laboratory accreditation, and internal quality improvement initiatives.
II
EVALUATION TOOLS: chart-stimulated recall, direct observation, and multisource evaluation.
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TABLE 1 Core Competency Components, continued
Competency Component Milestones (Months)
PRACTICE-BASED LEARNING AND IMPROVEMENT 12 24 36 Add
1 Identify knowledge and performance gaps and engage in opportunities to achieve focused education and
performance improvement.
I
2 Utilize decision support tools for accessing guidelines and pharmacologic information at the point of care. I
EVALUATION TOOLS: chart-stimulated recall, conference presentation, and global evaluation.
PROFESSIONALISM 12 24 36 Add
1 Forego recommending unvalidated diagnostic testing or treatments. I
2 Demonstrate a commitment to carry out professional responsibilities, appropriately refer patients, and
respond to patient needs in a way that supersedes self-interest.
II
3 Know and promote adherence to guidelines and appropriate use criteria. I
4 Interact respectfully with patients, families, and all members of the healthcare team, including ancillary and
support staff.
I
EVALUATION TOOLS: chart-stimulated recall, direct observation, and multisource evaluation.
INTERPERSONAL AND COMMUNICATION SKILLS 12 24 36 Add
1 Communicate with and educate patients and families across a broad range of cultural, ethnic, and
socioeconomic backgrounds.
I
2 Communicate with other specialists for optimal interdisciplinary management of patients. II
EVALUATION TOOLS: direct observation and multisource evaluation.
Add ¼ additional months beyond the 3-year cardiovascular fellowship.
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Level III training should provide trainees with the
knowledge and skills to interpret the clinical presenta-
tion, plan diagnostic testing, apply clinical and laboratory
information, and develop appropriate management plans
for patients with a variety of vascular disorders as a
vascular medicine specialist. This extends the knowledge
and skills acquired during Level I training to the entire
range of vascular diseases, as described in Sections 3.2
and 3.3 and outlined in Table 1, and includes perfor-
mance and interpretation of noninvasive vascular diag-
nostic examinations, as described in Section 4.2.3.
Fellows planning careers as vascular medicine special-
ists require advanced training beyond the 24 months of
clinical training required for board eligibility in cardio-
vascular medicine, typically during a 4th year dedicated
to this ﬁeld (1,2). Level I training in vascular medicine is a
prerequisite for Level III training, and Level II training can
be applied to Level III training, decreasing the time
required to gain Level III competence. Level III training
cannot be obtained during the standard 3-year cardio-
vascular fellowship and requires additional exposure in a
program meeting requirements that will be addressed in a
subsequent, separately published Advanced Training
Statement (formerly Clinical Competence Statement)
(1,2). The Level III trainee is expected to pass thecertiﬁcation examination offered by the ABVM (3). Fel-
lows seeking training in peripheral vascular interventions
should consult the COCATS 4 Task Force 10 report, which
integrates peripheral endovascular intervention with
other cardiovascular interventional training components.5. EVALUATION OF COMPETENCY
A key characteristic of the competency- and curricular
milestone–based system is integration with outcomes-
based evaluations. For training programs, evaluation
tools include a variety of modalities, such as direct
observation by instructors, in-training examinations,
procedure logbooks, conference and case presentations,
multisource evaluations, trainee portfolios, and simula-
tion. Case management, judgment, and interpretive and
technical skills must be evaluated in every trainee. An
optimum training environment includes bidirectional
evaluations in which faculty evaluate and provide posi-
tive or negative feedback to trainees, and trainees eval-
uate faculty after each rotation. The program director
should review these evaluations with the trainee and
faculty individually. Mechanisms should be incorporated
so that the fellow who performs suboptimally can be
counseled and further action can be taken if necessary.
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tence is expected for each of the speciﬁc Level I curricular
milestones. It is not expected, however, that the training
program formally evaluate each component (curricular
milestone) individually. Rather, evaluation tools may
focus on representative components in a given area. The
program director should record each trainee’s experi-
ences and performance of various patient care skills to
document satisfactory achievement at each level of
training. Trainees should maintain records of participa-
tion and advancement in the form of a Health Insurance
Portability and Accountability Act (HIPAA)–compliant
electronic database or logbook that meets ACGME
reporting standards and summarizes pertinent clinical
information (e.g., number of cases, diagnoses, disease
severity, outcomes, and disposition). The program direc-
tor is responsible for conﬁrming the experience and
competence of trainees. Under the aegis of the program
director, the faculty should record each trainee’s experi-
ences and assess performance to document satisfactory
achievement. The fund of knowledge regarding vascular
disease must be evaluated in every trainee. Quality of
clinical skills; reliability; judgment; actions that result in
complications; and interactions with other physicians,
patients, and laboratory support staff are key components
of the evaluation. Initiative and the ability to make in-
dependent and appropriate decisions should also be
assessed. The program director and Clinical Competency
Committee should speciﬁcally review the overall progressof individual trainees and achievement of selected
training milestones and identify areas in which additional
focused training is required.
Along with other professional organizations, including
the SVM, the ACC has formulated a clinical competence
statement on vascular medicine and catheter-based
vascular interventions (2). The SVM has deﬁned the
essential components of a specialized program for
training in vascular medicine (1). Self-assessment pro-
grams are available through the ACC. Training directors
and trainees are encouraged to incorporate these re-
sources in the course of training.
Evidence of competence can be ascertained by several
certiﬁcation examinations. The American Registry for
Diagnostic Medical Sonography (ARDMS) offers a certi-
fying examination for physicians performing and inter-
preting noninvasive vascular examinations (the
Physicians’ Vascular Interpretation Examination) for in-
dividuals completing the noninvasive vascular labora-
tory prerequisites during Level II or III training.
Information concerning the eligibility and prerequisites
for this examination can be obtained from the American
Registry for Diagnostic Medical Sonography (5). The
ABVM offers an examination for certiﬁcation in vascular
medicine for individuals completing Level III training.
Information concerning eligibility requirements can be
obtained from the ABVM (3). Additional information
regarding peripheral intervention is discussed in the
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